$9.51
6.58%
Nasdaq, Aug 29, 10:00 pm CET
ISIN
US23725P1003
Symbol
DRIO

DarioHealth Corp. Stock price

$9.51
-1.39 12.75% 1M
-4.41 31.67% 6M
-6.21 39.51% YTD
-6.69 41.30% 1Y
-85.69 90.01% 3Y
-316.89 97.09% 5Y
-2,503.29 99.62% 10Y
-107,270.49 99.99% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
-0.67 6.58%
ISIN
US23725P1003
Symbol
DRIO

Key metrics

Basic
Market capitalization
$22.8m
Enterprise Value
$31.2m
Net debt
$8.3m
Cash
$22.2m
Shares outstanding
45.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.8 | 0.8
EV/Sales
1.2 | 1.1
EV/FCF
negative
P/B
0.4
Financial Health
Equity Ratio
60.6%
Return on Equity
-56.9%
ROCE
-42.9%
ROIC
-55.2%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$27.2m | $27.2m
EBITDA
$-36.0m | $-17.1m
EBIT
$-42.3m | $-31.6m
Net Income
$-42.4m | $-22.0m
Free Cash Flow
$-26.9m
Growth (TTM | estimate)
Revenue
41.8% | 0.7%
EBITDA
37.2% | 65.5%
EBIT
32.8% | 44.5%
Net Income
8.8% | 46.2%
Free Cash Flow
34.2%
Margin (TTM | estimate)
Gross
55.0%
EBITDA
-132.5% | -62.6%
EBIT
-155.8%
Net
-156.3% | -80.9%
Free Cash Flow
-99.2%
More
EPS
$-0.8
FCF per Share
$-0.6
Short interest
0.4%
Employees
199
Rev per Employee
$140.0k
Show more

Is DarioHealth Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

DarioHealth Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a DarioHealth Corp. forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a DarioHealth Corp. forecast:

Buy
80%
Hold
20%

Financial data from DarioHealth Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
27 27
42% 42%
100%
- Direct Costs 12 12
8% 8%
45%
15 15
152% 152%
55%
- Selling and Administrative Expenses 39 39
15% 15%
142%
- Research and Development Expense 19 19
20% 20%
68%
-36 -36
37% 37%
-132%
- Depreciation and Amortization 6.32 6.32
10% 10%
23%
EBIT (Operating Income) EBIT -42 -42
33% 33%
-156%
Net Profit -42 -42
9% 9%
-156%

In millions USD.

Don't miss a Thing! We will send you all news about DarioHealth Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DarioHealth Corp. Stock News

Neutral
PRNewsWire
7 days ago
NEW YORK , Aug. 25, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced that a reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share (the "Common Stock") at a ratio of 20-for-1 is expected to be implemented at market open on August 28, 2025. The Company's C...
Neutral
Seeking Alpha
20 days ago
DarioHealth Corp. (NASDAQ:DRIO ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Chen Franco-Yehuda - CFO, Treasurer & Secretary Erez Raphael - CEO & Director Steven C. Nelson - President & Chief Commercial Officer Zoe Harrison - Corporate Participant Conference Call Participants Theodore Rudd O'Neill - Litchfield Hills Research, LLC Operator Good morning, ladie...
Neutral
PRNewsWire
21 days ago
Second quarter 2025 revenue was $5.4 million, compared to $6.3 million in the second quarter of 2024, and $6.8 million in the first quarter of 2025 - The Company believes that strong client momentum and strategic wins will offset decrease in revenues Approximately $5 million new committed annual recurring revenues ("CARR"); Plus $53 million pipeline of commercial opportunities, over $5 million ...
More DarioHealth Corp. News

Company Profile

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

Head office United States
CEO Erez Raphael
Employees 199
Founded 2011
Website shop.mydario.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today